semaglutide with other medications vs Diabetes Medications: A Pharmacist's Perspective The Untapped Promise of Obesity

These trials are mostly based on composite reductions in MACEs (similar to the original ELIXA trial endpoint)

Consistent B12 Levels

Several factors may explain why patients report hot flushes whilst taking Ozempic: Metabolic changes : Significant weight loss and alterations in body composition can affect thermoregulation Hormonal fluctuations : Weight loss may influence sex hormone levels, particularly oestrogen Blood glucose variations : Rapid changes in glycaemic control may trigger autonomic responses Concurrent medications or conditions : Many patients with type 2 diabetes take multiple medications that could contribute to vasomotor symptoms There is no official link established between Ozempic and hot flushes based on current evidence from randomised controlled trials

Resting heart rate A subset of community users report increased resting heart rate

In May, researchers announced the landmark finding that semaglutide, the compound in the common diabetes and weight-loss drugs Ozempic and Wegovy, also effectively reduced risks of kidney and heart complications and death in people with chronic kidney disease and type 2 diabetes

In combinatie met leefstijlveranderingen kan deze werking bijdragen aan gewichtsverlies